** Medical equipment maker Haemonetics' HAE.N shares fall 8.3% to $65.3 to touch an over 2-1/2 year low
** Co cuts its sales growth forecast for fiscal 2025 to 3%-5% from 5%-8%
** Co reports Q3 revenue of $349 million, missing analyst estimates of $353 million - data compiled by LSEG
** Co posts adj Q3 profit of $1.19 per share, beating analyst estimates of $1.17 per share - LSEG
** Shares are down ~17% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。